The mainstay treatment for patients with acute coronary syndrome is an oral route dual antiplatelet therapy with a P2Y12-receptor antagonist and Aspirin (ASA). To improve patient adherence to such treatments, combination therapies (polypill) are envisioned. Physicochemical solid-state studies have been carried out to develop a preformulation strategy of ASA with the P2Y12-receptor antagonist Ticagrelor (TIC). The investigations were carried out using differential scanning calorimetry, liquid chromatography-high resolution-multistage mass spectrometry (LC-HR-MS n ) and as complementary techniques Fourier transform infrared measurements and thermogravimetric analysis. A simple eutectic transition at 98°C with a mole fraction for the eutectic liquid of 0.457 has been observed and the mixing of ASA and TIC molecules in each other's crystal structures appears to be limited. No cocrystals of TIC and ASA have been found. The appearance of the eutectic liquid was linked with a clear onset of chemical instability of the two pharmaceuticals. The decomposition mechanism in the liquid phase involves prior decomposition of ASA, whose residues react with well-identified TIC interaction sites. Seven interaction products were observed by LC-HR-MS n linked to corresponding degradation products. The most important degradation pathway is N-dealkylation. In conclusion, polypills of ASA and TIC are a viable approach, but the decomposition of ASA should be avoided by eliminating high temperatures and high humidity.
Introduction
Cardiovascular diseases, and in particular acute coronary syndrome (ACS), remain the most serious life-threatening diseases (Engelmann and Massberg, 2013) . Dual antiplatelet therapy, consisting of Aspirin (ASA) and a P2Y12-receptor antagonist, is the mainstay treatment for patients with ACS. A complicating factor of a dual therapy is the necessity for patients to take multiple drugs, which diminishes patient adherence to the treatment. To avoid this kind of problems and to improve on the necessary doses of the different pharmaceuticals in a dual treatment, combination therapies (polypill) may be a solution.
However, the combined drug introduces the problem of possible interactions between the active ingredients. This may have an influence on their bioavailability, render the formulation inactive, or even toxic, as issues with drug-drug or drug-excipient interactions have been widely described in the literature (Almond and Janicki, 1974; Tischinger-Wagner et al., 1987; Horiuchi et al., 1997; Rajewski and Stella, 1997; Buckley and Benfield, 1993) . Chemical instabilities due to interactions can take the form of oxidation, reduction or hydrolysis (Almond and Janicki, 1974; Tischinger-Wagner et al., 1987) , and drug substances may even covalently bind to each other (Horiuchi et al., 1997) . Physical incompatibility may include a modification of the individual solubilities or the formation of a eutectic liquid, which will modify the formulation and also accelerate degradation of the pharmaceuticals (Rajewski and Stella, 1997; Buckley and Benfield, 1993) . It is therefore essential that combinations of active pharmaceutical ingredients are studied beforehand. In particular, the chemical and physical behaviour of the mixtures is of importance, as they may be the first to indicate what will happen to the final mixed drug product. The outcome can then be used in the preformulation strategy to stabilize the drug.
In the present paper, the chemical and physical stability of mixtures of ASA with the P2Y12-receptor antagonist Ticagrelor (TIC) will be studied to support the development of a combination therapy with these two active ingredients. The dosage quantities of TIC are rather well defined at 90 mg per tablet (James et al., 2009 ). In the case of ASA, it is well known that high doses are associated with higher rates of major bleeding in patients (Berger et al., 2012) . A large systematic review on the efficacy of ASA to avoid blood clots has demonstrated that there are no differences in clinical outcome between low or high doses of ASA in the medical treatment following surgical stent insertions (Berger et al., 2012) , thus for a combination therapy an effective ASA dosage quantity can be kept at a relatively low concentration. A double blind clinical trial evaluation of the pharmacokinetics and pharmacodynamics of Ticagrelor co-administered with 300 mg qd. of Aspirin in healthy volunteers has demonstrated that simultaneous administration of TIC and ASA does not affect the medical treatment negatively (Renli et al., 2013) .
According to the literature, ASA melts around 138°C with a melting enthalpy of 185 J g − 1 (Myers, n.d.; Aulton and Taylor, 2013) . It is also well known that ASA rapidly decomposes in the presence of water, while forming acetic acid and salicylic acid (Carstensen and Attarchi, 1988a) . In the case of TIC, a single patent exists describing four polymorphs called I, II, III and IV melting at 128, 135, 139 and 150°C respectively (Bohlin et al., 2003) . Previously, the chemical behaviour of TIC under several stress conditions has been investigated, which resulted in the elucidation of nine main degradation products formed through oxidation, S-dealkylation and N-dealkylation mechanisms (Sadou Yaye et al., 2015) . Taking into account the physical and chemical properties of the pure compounds, mixtures of ASA and TIC will be investigated using differential scanning calorimetry (DSC) and liquid chromatography-high resolution-multistage mass spectrometry (LC-HR-MS n ) and as complementary techniques Fourier Transform Infrared measurements (FTIR) and thermogravimetric analysis (TGA).
Materials and methods

Materials
Ticagrelor of a purity greater than 98% was obtained from Interchim® (Montluçon, France). Acetylsalicylic acid (purity: 99.5%) was purchased from Cooper (Melun, France). Analytical grade acetonitrile was provided by Sigma-Aldrich (St Quentin-Fallavier, France). Ultrapure water from Q-Pod Milli-Q system (Millipore, Molsheim, France) was used for dissolution, dilution, and as a component of the mobile phase.
Solid-state stress testing
TIC and ASA substances were dried at 80°C in an oven for 24 h, then mixed (1:1 molar ratio) by gentle grinding using a mortar and a pestle for 5 min. 50 mg of the two APIs and their mixture were prepared in triplicate, placed in a calibrated hot-air oven at 80°C, and at 100°C and removed after either 1 day or 3 days of exposure.
In parallel, kinetic studies were performed. Samples of about 10 mg of TIC-ASA mixtures were prepared in triplicate and placed in ovens at 25, 40, 60, 70, 80, and 90°C ( ± 1°C) . The samples were removed at 0, 1, 2, 3, 7, 14, 21, and 28 days and analysed by HPLC. Concurrently, TIC, ASA and TIC-ASA mixture control samples stored at 25°C for one year have been tested for degradation products.
Analytical methods
Differential scanning calorimetry
DSC experiments were performed using a Q1000 (TA Instruments, USA) heat-flux calorimeter. It was calibrated before use with high purity indium (T fus = 156.60°C) and tin (T fus = 231.91°C) standards. Drug mixture samples of approx. 1.5-4 mg were scanned in sealed aluminum pans at a rate of 10 K min
, from 30 to 160°C, in an inert N 2 atmosphere with a purge flow rate of 50 cm 3 min − 1 . For temperature-composition diagrams, binary physical mixtures with TIC-ASA concentrations of (mol fraction TIC): 1. 00, 0.95, 0.90, 0.80, 0.70, 0.60, 0.50, 0.40, 0.30, 0.20, 0.10, 0 .05, and 0.00 were prepared by gentle mixing and grinding of the two compounds using a mortar and a pestle for 5 min, then the melting behaviour of the samples were assessed by DSC. Subsequently, heating-cooling cycles of selected samples were carried out. Additionally, the crucibles were retrieved, opened, dissolved in 1 mL of acetonitrile, sonicated for 10 min, and analysed by LC-HR-MS n .
X-ray powder diffraction
A Debye-Scherrer optics was used with an INEL powder diffractometer equipped with a cylindrical position-sensitive detector (CPS120) containing 4096 channels (0.029°2θ angular step) and monochromatic Cu Kα 1 (λ = 1.54061 Å) radiation. Slightly ground specimens were introduced in a Lindemann capillary (0.5 mm diameter) rotating perpendicularly to the X-ray beam during the experiments to improve the average over the crystallite orientations.
Thermal gravimetric analysis
TG measurements were carried out using a TA instruments Q500 thermogravimetric analyzer (TGA) equipped with a precision thermobalance (0.1 μg). The weighted samples (3-8 mg) were heated from 25°C to 600°C. Heating runs were carried out under nitrogen atmosphere at three heating rates: 5, 10 and 20 K min − 1 .
Fourier transform infrared measurements
FTIR was used to assess the modification of the molecular environment of the APIs induced in the physical mixture (0.30 mole fraction TIC). The experiments were performed on a Perkin-Elmer Spectrum BX FT-IR system based on diffuse reflectance sampling accessories with FT-IR Spectrum v2.00 software. The spectra of the APIs, their mixtures and the corresponding stressed samples were recorded at room temperature in the wavenumber range of 400-4000 cm − 1 using KBr pellets.
2.3.5. High pressure liquid chromatography A Dionex Ultimate 3000 LC system (DIONEX, Les Ulis, France) was used to separate the APIs and their degradation/interaction products from the stress samples and the DSC crucibles. The system consisted of a quaternary pump, a degasser, a thermostated autosampler with a 200 μL-injection syringe, and a thermostated column compartment. A C18 (Phenomenex®) (150 mm × 4.6 mm, 4 μm) column set at 25°C was used. The optimized LC parameters include the mobile phase composition (phase A: acetonitrile, phase B: water) set in a gradient method (A 20% v/v from 0 to 5 min; A 20% to 60% v/v from 5 to 7 min; A 60→ 80% v/v from 15 to 17 min; A 80→ 20% v/v from 17 to 20 min and A 20% v/v till 25 min). The flow-rate was set at 1 mL min − 1 .
2.3.6. LC-high-resolution multistage mass spectrometry LC-HR-MS n was used to elucidate the structures of the decomposition products following DSC and stress tests. It was performed by coupling a Dionex® LC system to an electrospray (ESI)-LTQ-Orbitrap Velos Pro system, which comprises a double linear trap and an orbital trap (Thermo Fisher Scientific, CA, USA). Analyses were carried out in positive and negative ion mode for TIC and ASA respectively, under the following conditions: (a) the source voltage was set at 3.4 kV; (b) the temperatures were fixed at 53°C (source) and 300°C (capillary); (c) SLens was set at 60%. Acquisition in full scan mode over the mass range of 50-600 Da was performed for the detection of the degradation products. 30-40% CEL were set for high-resolution fragmentation studies. The MS data were processed using Xcalibur® software (version 2.2 SP 1.48).
Results and discussion
3.1. Physical stability in the solid mixtures of TIC and ASA
For the pure compounds the following melting data were found: TIC led to a T onset = 136.2 ± 1.9°C and a Δ H fus = 81 ± 5 J g − 1 and ASA melts at 138.1 ± 2.5°C with a Δ H fus at 184.5 ± 13.1 J g − 1 . The melting data and the X-ray pattern ( Fig. S1 ) of Aspirin sample used were found to be consistent with the Aspirin form I (Myers, n.d.; Aulton and Taylor, 2013; Kim et al., 1985) . The melting point of TIC in combination with an X-ray diffraction pattern ( Fig. S2 ) for verification indicates that the TIC sample contained pure form II according to the information provided in the patent (Bohlin et al., 2003) . Physical mixtures were prepared by gently grinding different mole fractions of TIC and ASA as indicated in the experimental section. The mixtures were subsequently subjected to DSC measurements in a closed capsule by heating the samples at a rate of 10 K min − 1 from 30°C up to 160°C. The DSC curves exhibited two endothermic peaks indicative of the occurrence of a eutectic and a liquidus transition (see Fig. 1a ) (Vargha, 2007; Herman et al., 2012; Diarce et al., 2015) . The onset temperature of the eutectic peak, 98°C, and the peak maximum of the liquidus peak were used to plot the temperature-composition TIC-ASA phase diagram (Fig. 1b) . The dependence of the eutectic molar enthalpy with the mole fraction of TIC, the Tammann plot, was used to estimate the eutectic composition (see Fig. 1c ) (Guenet, 1996; Rycerz, 2013) . The ASA rich side of the Tammann plot led to the following equation: Δ H eutectic (x) = 62,249 · x and the TIC rich side led to the equation Δ H eutectic (x) = − 52,298 · x + 52,398. With these two expressions a eutectic mole fraction of 0.457 was calculated. Considering the Tammann plot and the T-x phase diagram, the TIC-ASA system exhibits a simple eutectic transition at 98°C with a mole fraction for the liquid of 0.457 ( Fig. 1b-c) .
A eutectic equilibrium consists of an equilibrium between three phases and can be written as solid1 + solid2 ⇄ liquid, for which the concentration of the liquid is found in between those of the two solids. The fundamental equilibrium conditions require the chemical potentials of the two components TIC and ASA to be equal in each phase, which in turn implies that each of these components must be present in the three phases in equilibrium (Goldberg et al., 1965; Bi et al., 2003; Law et al., 2003; Singh et al., 2008; Moore and Wildfong, 2009; Jain et al., 2014) . In other words the two solids in equilibrium are solid solutions one of which consists mainly of TIC with some ASA and the other consists mainly of ASA with some TIC. The experimental question is therefore to what level ASA molecules can be found in TIC and vice versa. For each binary mixture in which the relative amounts of the components are both large enough to form the two solid phases, heating will give rise to the eutectic liquid and a heat effect related to the eutectic transition will be observed in the DSC. However, if the concentration of one of the components is sufficiently low that it can completely 'dissolve' in the crystal structure of the other component, thus when only a single solid solution is present in the system, the eutectic transition will not be observed, because the single solid phase will have a different melting behaviour and the eutectic heat effect will be equal to zero. The intersection of the Tammann plot -the eutectic enthalpy effect plotted against the binary composition -with the composition axis will therefore provide an indication of the extent of the solid solution in terms of concentration. In the present case, the enthalpy effect of the eutectic transition appears to extend to the pure compositions as the Tammann plot intersects the composition axis at 0 and at 1 mole fraction. Therefore, it can be concluded that the extent of the solid solutions, i.e. the mixing of ASA in solid TIC and of TIC in solid ASA, is probably limited in this system. Moreover, considering the observed eutectic transition, it can be concluded that interactions in the form of binary compounds (or cocrystals) seem to be absent in this system. 3.2. Chemical stability in mixtures with TIC and ASA 3.2.1. Thermal stress testing
It can be seen in Table 1 that the physical appearance of pure TIC and of pure ASA kept at 80°C and 100°C does not change. A mixture of ASA and TIC (1:1 molar ratio) retains the same appearance for 1 day at 80°C. However, the powder becomes yellowish when left at 80°C for three days. In the case of 100°C, the change in colour is observed within one day.
It is clear from the preceding results that chemical interactions occur in the mixtures of TIC and ASA. It should be kept in mind that at 80°C the mixture will be solid, whereas at 100°C part of the mixture will have become liquid, as the eutectic temperature has been passed.
The samples have been investigated by LC-HR-MS n . The fragmentation pattern of TIC was obtained in a previous publication (Sadou Yaye et al., 2015) . Those results will be used to analyse the interaction and degradation products in the present mixture with TIC and ASA. In the LC-HR-MS n results, the interaction products (IPs) are defined as those stemming from the entire TIC molecule attached to other molecular moieties in particular from ASA. In addition, degradation products (DPs) are defined as those with a smaller mass stemming from TIC directly or from one of the IPs. Once an IP or a DP has been identified, the elemental composition is deduced and the mass error is calculated for verification (see Table 2 ).
3.2.1.1. Pure APIs. LC-HR-MS n did not reveal any degradation product in the case of the pure active pharmaceutical ingredients that were kept for one day at 80°C. It has been verified by LC-HR-MS n that heating samples of pure TIC in the DSC up to 160°C did not lead to any degradation products either. These results are consistent with the absence of change in the physical aspect of the pure compounds. For ASA, it is known that it rapidly decomposes into salicylic acid and acetic acid (Carstensen and Attarchi, 1988a) in the liquid phase.
3.2.1.2. Degradation kinetics of the mixture For each temperature, the remaining TIC-ASA in the mixtures has been plotted as a function of time (Fig. 2a , Table S1 ). The decomposition data has been fitted to zero order expressions, which gave reasonable fits within the limits of precision of the data. The rate constants have been assembled in an Arrhenius plot (Fig. 2b) . The activation energy of the observed decomposition reaction of 130 ± 12 kJ mol ) (Carstensen and Attarchi, 1988b) . The ratelimiting step in the decomposition of the TIC-ASA mixture may therefore depend on the decomposition of ASA and the reaction products Tests performed on TIC-ASA samples stored for one year at 25°C do not reveal any decomposition products, so the 1% obtained by the Arrhenius equation might be an upper limit of the decomposition estimate. How the decomposition of ASA affects TIC will be discussed in the next section.
3.2.1.3. Interaction products observed in the TIC-ASA mixture. As indicated in Table 2 , seven interaction products have been identified named IP1 to IP7. They respectively exhibit masses with 28, 42, 84, 126, 120, 162, and 204 amu higher than that of the TIC molecule. It can be deduced that they respectively represent carbon monoxide-TIC, acetyl-TIC, diacetyl-TIC, triacetyl-TIC, TIC-salicylate, acetyl-TICsalicylate and diacetyl-TIC-salicylate, as indicated in Table 2 . Four possible TIC interaction sites can be identified, three alcohol functions and a secondary arylamine, as indicated in Fig. 3b . A transition in relation to an interaction with the secondary arylamine on the TIC molecule is for example characterized by the neutral loss of the hydroxyethoxycyclopentane-1,2-diol moiety. An interaction with the primary alcohol is characterized by the absence of the neutral loss of ethanal or ethyleneglycol. The presence of the two latter transitions would suggest consequently an interaction with the cyclopentane alcohols. As a result, for the observed products, several LC-separated isomers can be found corresponding to the different interaction combinations on the aforementioned sites (see for example the different peaks for IPs2 and IPs3 in Fig. 3a) .
For the product with m/z 565, the number of IPs was superior to that of the interaction sites, which suggests the formation of stereoisomeric products. In fact, in the case that the acetylation involves only one of the cyclopentane diols, the formation of a hydrogen bond with the free OH may yield a hydrogen bond depending on the position of the carbonyl function. This is suggested by the difference in their spectrums, which differ in weight indicative of a water molecule.
3.2.1.4. Proposed pathways for the observed degradation products in TIC-ASA mixtures. In our previous study, we have demonstrated that TIC gives rise to the degradation product m/z 371 by N-dealkylation when it is subjected to 80°C in solution (Sadou Yaye et al., 2015) . However, the interaction with ASA increased the appearance of this dealkylation product ten-fold. In addition, seven degradation products DP1 to DP7 were obtained as a result of the N-dealkylation from the interaction products IP1 to IP7. Thus, the arylamine is clearly the main interaction and degradation site of TIC in the presence of ASA.
Besides the formation of acetic acid and salicylic acid, CO 2 and/or CO probably from acetic acid (Mackie and Doolan, 1984; Park and Lee, 2009 ) could be observed to interact with TIC. This is illustrated in fig. 4 , where TIC is presented with an attached carbonyl group and the possible fragmentation pathways.
From the foregoing, it can be concluded that the presence of ASA may affect the chemical stability of TIC in the solid state at elevated temperatures.
3.2.2. Degradation around the eutectic temperature 3.2.2.1. The effect of liquid formation on the degradation process. It has been shown that the presence of ASA may affect the chemical stability of TIC at elevated temperature. Considering that the eutectic temperature is found around 98°C, the effect of the formation of a liquid on the chemical stability of TIC in the presence of ASA should be evaluated.
The eutectic mixtures were subjected to a heating-cooling cycle with a heating (cooling) rate of 10°C min − 1 up to the T peak of the eutectic transition (=100°C) and in certain cases up to the end of the liquidus (= 130°C), after which the samples were cooled. The pans were collected and the residues were analysed by LC-HR-MS n in positive mode.
As illustrated in Fig. 5a , immediate cooling after passing the eutectic temperature generated only one interaction product with m/z 565.2020, which represents an acetylation product of TIC as has been demonstrated above. By passing the liquidus temperature for a mixture of about 0.3 mole fraction of TIC at around 120°C, the intensity of the former interaction product increases significantly along with the appearance of two of its other isomers (Fig. 5b) . Hence, it is clear that the acetylation of TIC plays an important role in its degradation process. Furthermore, contrary to the solid state, where the chemical interactions only slowly evolved, the liquid state gives almost immediately rise to one of the main degradation products, which next to the increased thermal activation energy, can be ascribed to the increase of the molecular mobility of the two APIs in the liquid (Yoshioka and Aso, 2007) .
Additional evidence by FT-IR. Several measurements by FT-IR
were carried out to investigate to what extent FT-IR can be used to demonstrate the progress of degradation in TIC-ASA mixtures. It can be shown that the pure APIs subjected to 100°C for 7 days do not exhibit substantial changes in their FT-IR spectra in comparison with the samples that were kept at room temperature for the same duration nor with the spectra of the samples obtained before heating evidenced by the excellent superposition of the different spectra (see Fig. 6a spectra a, b, f, and g).
In the FT-IR spectra of the TIC-ASA physical mixture at T0 and 25°C, the characteristic peaks of the two pure drug substances can be recognized with no other new band present (compare Fig. 6a spectra c  and d with spectra a and g ). This confirms that the extent of the solid solutions is limited as observed by DSC.
However, the TIC-ASA physical mixture heated for seven days at 100°C revealed a few clear changes (Fig. 6a spectrum 
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significant decrease of the OH deformation bands (of about 40%) between 1423 and 1550 cm − 1 .
-The lack of the stretching vibration band at 1748 cm − 1 assigned to the ester carbonyl group of ASA, followed by a significant increase (of about 20%) of the band of the carbonyl acid, red-shifted from 1748 to 1700 cm − 1 , and the appearance of a broad shoulder on the right. -In the fingerprint region from 1100 to 500 cm − 1 , huge changes in shape and intensity were observed in comparison to the spectra for the mixture at 25°C.
These results confirm the chemical interactions between TIC and ASA at elevated temperature. It is clear however, that FT-IR is not very sensitive to small chemical changes in the samples.
3.2.2.3. Evaporation and its effect on TIC-ASA mixtures. To further elucidate the degradation process of TIC and ASA, mixtures and the pure compounds have been studied by thermal gravimetric analysis. The TG curves of ASA and TIC under nitrogen atmosphere are presented in Fig. 7 . For ASA, its fusion is directly followed by two successive mass losses. The first mass loss is the result of the separation between salicylic acid and acetic acid with a possible formation of CO and CO 2 as observed in our results above. This first loss is most likely accompanied by the formation of previously described ASA polymer (Silva et al., 2004) . The second mass loss is obviously the evaporation/pyrolysis of this polymer.
It is clear from the TG curve of pure TIC that it is much more stable than ASA, as its mass loss only starts around 300°C, far above its melting temperature. This resistance to high temperature could be explained by the chemical structure of TIC, which consists of a purine nucleoside core, which is known to possess a high thermal resistance (Wang and You, 2015) . Moreover, other groups are present which can resist high temperatures relatively easily such as the aryl ring, OH, and NH, of which the latter two also form strong intermolecular hydrogen bonds that are difficult to break (Mohamed et al., 2016) .
Mixtures of 0.3, 0.4, and 0.8 TIC mole fraction were subjected to the TG measurements. It can be seen in Fig. 7 that the mass loss patterns of the three mixtures fully fall within the two extremes defined by the behaviour of pure TIC and pure ASA. There does not seem to be any clear evidence of an interaction between ASA and TIC in the mixtures as the curves are to a large extent simply the weighed sum of the curves of the pure compounds. Apparently, the acetyl moiety, which in the stress test appeared to play an important role in the degradation of TIC, does not have the chance to interact with TIC. This may be rather logical when one realises that the boiling point of acetic acid is 118°C, which implies that the molecule and its derivatives will rapidly evaporate in the TG experiment. This is clearly in contrast to the previous investigations, where the temperature was consistently held below 118°C. In the case of the TG experiment, acetic acid will form around 100°C at the eutectic temperature, when a liquid is formed, and subsequently within 2 min the temperature will have reached 120°C, when the acetic acid will quickly evaporate from the mixture.
Hence, it is clear from the preceding results that the separation of ASA into salicylic acid and acetic acid is at the core of the degradation of TIC, when mixed. This is also supported by the findings in relation to the reaction rate, which appears to depend mainly on the decomposition of ASA. 
Concluding remarks and pharmaceutical implications of the interactions
The temperature-composition phase diagram of TIC form II and ASA has been constructed and it has been demonstrated through the eutectic phase diagram and the Tammann curve that physical interaction between the two APIs in the solid state in the form of cocrystals seems to be absent and in the form of solid solutions is probably limited. The solid mixture appears to be stable at room temperature at least for a year, but the formation of acetic acid originating from ASA should be avoided. It has clearly been shown that this is one of the major products that causes the degradation of TIC, when in contact with ASA. LC-HR-MS n characterization of the degradation/interaction products (DPs/IPs) revealed the strong interaction between the donor and acceptor sites of the two APIs. The main mechanism of TIC degradation involved Ndealkylation as demonstrated by the degradation products formed from the interaction products between ASA and TIC.
Although the polypill concept presents many advantages in terms of patient compliance (Wiley and Fuster, 2014) , inappropriate manufacturing processes or storage conditions may lead to chemical instability and compromise the drug. For example, even at room temperature, ASA can undergo moisture-catalysed hydrolysis (Carstensen and Attarchi, 1988b ) and degradation of TIC-ASA mixtures are expected under humid conditions. Moreover, TIC-ASA interactions generate hydrophilic (DPs) and lipophilic (IPs) products, which alter the pharmacokinetics and pharmacodynamics of the drug and hence reduce the potency (Springthorpe et al., 2007) . Furthermore, ASA induced degradation of TIC generates primary arylamine through the N-dealkylation process, which are reported to participate in the metabolic activation by cytochrome P450, which may generate mutagenic and carcinogenic metabolites (Wogan et al., 2004; Turesky et al., 1998; Benigni et al., 2000) .
It has been shown in this paper, that there is a clear interaction between ASA and TIC and how to avoid it, information that can be used European Journal of Pharmaceutical Sciences 107 (2017) 62-70 for the development of a combination therapy with ASA and TIC. It is clear that scientific research is indispensable to provide relevant information for preformulation strategies and quality risk assessment for the drug life cycle (ICH, 2003; ICH, 2009; ICH, 2005) . Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.ejps.2017.06.031. 
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